NCT02485847 IRIS Registry: Intelligent Research in Sight Registry
| NCT ID | NCT02485847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | American Academy of Ophthalmology |
| Condition | Eye Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000,000 participants |
| Start Date | 2014-03 |
| Primary Completion | 2100-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000,000 participants in total. It began in 2014-03 with a primary completion date of 2100-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.
Eligibility Criteria
Inclusion Criteria: * Patients who meet the denominator requirements for each measure. Exclusion Criteria: * None
Contact & Investigator
Flora Lum, MD
STUDY DIRECTOR
American Academy of Ophthalmology
Frequently Asked Questions
Who can join the NCT02485847 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, studying Eye Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02485847 currently recruiting?
Yes, NCT02485847 is actively recruiting participants. Contact the research team at irisregistry@aao.org for enrollment information.
Where is the NCT02485847 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT02485847 clinical trial?
NCT02485847 is sponsored by American Academy of Ophthalmology. The principal investigator is Flora Lum, MD at American Academy of Ophthalmology. The trial plans to enroll 20,000,000 participants.